Oligodendroglioma Cells Lack Glutamine Synthetase and Are Auxotrophic for Glutamine, but Do not Depend on Glutamine Anaplerosis for Growth-Reference-Cited by-同舟云学术

Oligodendroglioma Cells Lack Glutamine Synthetase and Are Auxotrophic for Glutamine, but Do not Depend on Glutamine Anaplerosis for Growth

Published:2018-04-06 Issue:4 Volume:19 Page:1099
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Chiu Martina,Taurino Giuseppe,Bianchi Massimiliano,Ottaviani Laura,Andreoli Roberta,Ciociola Tecla,Lagrasta Costanza,Tardito Saverio,Bussolati Ovidio^ORCID

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/19/4/1099/pdf

Reference54 articles.

1. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

2. Glutamine addiction: a new therapeutic target in cancer

3. Glutamine Metabolism in Cancer: Understanding the Heterogeneity

4. Glutamine: pleiotropic roles in tumor growth and stress resistance

5. Differential regulation of mTORC1 by leucine and glutamine

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mechanism of extracellular CypB promotes glioblastoma adaptation to glutamine deprivation microenvironment;Cancer Letters;2024-08

2. Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas;Briefings in Bioinformatics;2024-03-27

3. Glutamine Promotes Porcine Intestinal Epithelial Cell Proliferation through the Wnt/β-Catenin Pathway;Journal of Agricultural and Food Chemistry;2024-03-25

4. The SLC38A5/SNAT5 amino acid transporter: from pathophysiology to pro-cancer roles in the tumor microenvironment;American Journal of Physiology-Cell Physiology;2023-08-01

5. Glutamine metabolism in cancers: Targeting the oxidative homeostasis;Frontiers in Oncology;2022-10-17